|
|
| | Febuxostat Impurity 7 Basic information |
| Product Name: | Febuxostat Impurity 7 | | Synonyms: | Febuxostat Impurity 7;(Z)-2-(3-((hydroxyimino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid;Febuxostat Impurity M;2-(3-((Hydroxyimino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylicacid;Febuxostat impurities 7;5-Thiazolecarboxylic acid, 2-[3-[(hydroxyimino)methyl]-4-(2-methylpropoxy)phenyl]-4-methyl-;2-[3-((hydroxyimino)methyl)-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylicacid;sodium-2-(3-((hydroxyimino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | | CAS: | 1350352-70-3 | | MF: | C16H18N2O4S | | MW: | 334.39 | | EINECS: | | | Product Categories: | | | Mol File: | 1350352-70-3.mol |  |
| | Febuxostat Impurity 7 Chemical Properties |
| Melting point | >215°C (dec.) | | storage temp. | -20°C Freezer | | solubility | DMSO (Slightly) | | form | Solid | | color | White |
| | Febuxostat Impurity 7 Usage And Synthesis |
| Uses | 3-Descyano-3-((hydroxyimino)methyl) Febuxostat is an impurity of Febuxostat (F229000), a xanthine oxidase/xanthine dehydrogenase inhibitor that is used for treating hyperuricemia and chronic gout. |
| | Febuxostat Impurity 7 Preparation Products And Raw materials |
|